A Case of Unnecessary Panic: Dengue Infection during Anti-TNF Treatment for Psoriasis
Open Access
- 1 September 2017
- journal article
- case report
- Published by SAGE Publications in Journal of Psoriasis and Psoriatic Arthritis®
- Vol. 2 (4) , 83-84
Abstract
We report a patient who was infected by dengue virus during a rare epidemic in Argentina. As he was receiving anti-TNF therapy for psoriasis, we were afraid he might have a bad outcome. The patient had a good resolution, however, and a literature review showed that while TNF plays a very important role in the development of dengue fever symptoms, the use of anti-TNF drugs seems not to worsen the course of the disease, and might even protect patients from severe disease.Keywords
This publication has 7 references indexed in Scilit:
- Emerging infectious diseases with cutaneous manifestationsJournal of the American Academy of Dermatology, 2016
- Clinical significance of skin rash in dengue fever: A focus on discomfort, complications, and disease outcomeAsian Pacific Journal of Tropical Medicine, 2016
- Dengue fever in patients under biologicsJournal of Clinical Virology, 2014
- Poster AbstractsJournal of the American Academy of Dermatology, 2012
- Anti-TNF antibody treatment reduces mortality in experimental dengue virus infectionFEMS Immunology & Medical Microbiology, 2003
- Human skin Langerhans cells are targets of dengue virus infectionNature Medicine, 2000
- The Alexander D. Langmuir Lecture THE PATHOGENESIS OF DENGUEAmerican Journal of Epidemiology, 1981